- Home
- PLSE vs OMCL Comparison
PLSE vs OMCL Comparison
Compare PLSE & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | OMCL |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PLSE | OMCL |
|---|---|---|
| Price | $25.30 | $43.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $22.00 | ★ $55.83 |
| AVG Volume (30 Days) | 326.9K | ★ 619.6K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $840.00 | $6.77 |
| Revenue Next Year | $287.54 | $5.22 |
| P/E Ratio | ★ N/A | $171.98 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $12.56 | $26.85 |
| 52 Week High | $27.98 | $51.84 |
Technical Indicators
Market Signals| Indicator | PLSE | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 61.28 | 60.39 |
| Support Level | $17.58 | $43.34 |
| Resistance Level | $26.30 | $46.11 |
| Average True Range (ATR) | 1.72 | 1.85 |
| MACD | 0.59 | -0.08 |
| Stochastic Oscillator | 74.53 | 44.37 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.